1. Home
  2. BWEN vs SER Comparison

BWEN vs SER Comparison

Compare BWEN & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWEN
  • SER
  • Stock Information
  • Founded
  • BWEN N/A
  • SER 2017
  • Country
  • BWEN United States
  • SER United States
  • Employees
  • BWEN N/A
  • SER N/A
  • Industry
  • BWEN Industrial Machinery/Components
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWEN Industrials
  • SER Health Care
  • Exchange
  • BWEN Nasdaq
  • SER Nasdaq
  • Market Cap
  • BWEN 49.1M
  • SER 55.2M
  • IPO Year
  • BWEN N/A
  • SER 2018
  • Fundamental
  • Price
  • BWEN $2.29
  • SER $4.61
  • Analyst Decision
  • BWEN Strong Buy
  • SER Strong Buy
  • Analyst Count
  • BWEN 1
  • SER 2
  • Target Price
  • BWEN $6.00
  • SER $13.00
  • AVG Volume (30 Days)
  • BWEN 297.1K
  • SER 42.4K
  • Earning Date
  • BWEN 11-13-2025
  • SER 11-11-2025
  • Dividend Yield
  • BWEN N/A
  • SER N/A
  • EPS Growth
  • BWEN N/A
  • SER N/A
  • EPS
  • BWEN N/A
  • SER N/A
  • Revenue
  • BWEN $145,141,000.00
  • SER $130,000.00
  • Revenue This Year
  • BWEN $8.75
  • SER $134.46
  • Revenue Next Year
  • BWEN $3.50
  • SER N/A
  • P/E Ratio
  • BWEN N/A
  • SER N/A
  • Revenue Growth
  • BWEN N/A
  • SER N/A
  • 52 Week Low
  • BWEN $1.41
  • SER $3.81
  • 52 Week High
  • BWEN $3.03
  • SER $7.92
  • Technical
  • Relative Strength Index (RSI)
  • BWEN 51.15
  • SER 40.02
  • Support Level
  • BWEN $2.18
  • SER $4.60
  • Resistance Level
  • BWEN $2.37
  • SER $5.00
  • Average True Range (ATR)
  • BWEN 0.19
  • SER 0.25
  • MACD
  • BWEN -0.01
  • SER -0.04
  • Stochastic Oscillator
  • BWEN 21.23
  • SER 1.45

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: